Global Anorexiants Market By Drug Class (Catecholamines, Serotonin) By Route of Administration (Oral, Subcutaneous) By End User (Institutional Sales, Hospitals & Clinics, Retail Sales, Online Pharmacies, Others) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Jan 2025
Report ID: 137503
Number of Pages: 233
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Anorexiants Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    
    2.9.1. List of Raw Materials Suppliers
    
    2.9.2. List of Anorexiants Manufacturers
    
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Anorexiants Market Analysis and Forecast, By Segment, 2019-2033
  - 3.1. Key Findings
  - 3.2. Global Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 3.3. Global Anorexiants Market Attractiveness Analysis, By Drug Class
    
    3.3.1. Catecholamines
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Serotonin
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
  - 3.4. Global Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  - 3.5. Global Anorexiants Market Attractiveness Analysis, By Route of Administration
    
    3.5.1. Oral
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Subcutaneous
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
  - 3.6. Global Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  - 3.7. Global Anorexiants Market Attractiveness Analysis, By End User
    
    3.7.1. Institutional Sales
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Hospitals & Clinics
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Retail Sales
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
    
    3.7.4. Online Pharmacies
    
    3.7.4.1. Insights
    
    3.7.4.2. Key Takeaways
    
    3.7.5. Others
    
    3.7.5.1. Insights
    
    3.7.5.2. Key Takeaways
- 4. Global Anorexiants Market Analysis and Forecast, By Region, 2019-2033
  - 4.1. Key Findings
  - 4.2. Global Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Anorexiants Market Attractiveness Analysis, By Region
- 5. North America Anorexiants Market Analysis and Forecast, 2019-2033
  - 5.1. Key Findings
  - 5.2. North America Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 5.3. North America Anorexiants Market Attractiveness Analysis, By Drug Class
  - 5.4. North America Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  - 5.5. North America Anorexiants Market Attractiveness Analysis, By Route of Administration
  - 5.6. North America Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  - 5.7. North America Anorexiants Market Attractiveness Analysis, By End User
  - 5.8. North America Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 5.9. North America Anorexiants Market Attractiveness Analysis, By Country
    
    5.9.1. The US
    
    5.9.2. Canada
- 6. Europe Anorexiants Market Analysis and Forecast, 2019-2033
  - 6.1. Key Findings
  - 6.2. Europe Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 6.3. Europe Anorexiants Market Attractiveness Analysis, By Drug Class
  - 6.4. Europe Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  - 6.5. Europe Anorexiants Market Attractiveness Analysis, By Route of Administration
  - 6.6. Europe Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  - 6.7. Europe Anorexiants Market Attractiveness Analysis, By End User
  - 6.8. Europe Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 6.9. Europe Anorexiants Market Attractiveness Analysis, By Country
    
    6.9.1. Germany
    
    6.9.2. The UK
    
    6.9.3. France
    
    6.9.4. Spain
    
    6.9.5. Italy
    
    6.9.6. Russia
    
    6.9.7. Netherland
    
    6.9.8. Rest of Europe
- 7. Asia Pacific Anorexiants Market Analysis and Forecast, 2019-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 7.3. Asia Pacific Anorexiants Market Attractiveness Analysis, By Drug Class
  - 7.4. Asia Pacific Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  - 7.5. Asia Pacific Anorexiants Market Attractiveness Analysis, By Route of Administration
  - 7.6. Asia Pacific Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  - 7.7. Asia Pacific Anorexiants Market Attractiveness Analysis, By End User
  - 7.8. Asia Pacific Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 7.9. Asia Pacific Anorexiants Market Attractiveness Analysis, By Country
    
    7.9.1. China
    
    7.9.2. Japan
    
    7.9.3. South Korea
    
    7.9.4. India
    
    7.9.5. Australia
    
    7.9.6. New Zealand
    
    7.9.7. Singapore
    
    7.9.8. Thailand
    
    7.9.9. Vietnam
    
    7.9.10. Rest of Asia Pacific
- 8. Latin America Anorexiants Market Analysis and Forecast, 2019-2033
  - 8.1. Key Findings
  - 8.2. Latin America Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 8.3. Latin America Anorexiants Market Attractiveness Analysis, By Drug Class
  - 8.4. Latin America Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  - 8.5. Latin America Anorexiants Market Attractiveness Analysis, By Route of Administration
  - 8.6. Latin America Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  - 8.7. Latin America Anorexiants Market Attractiveness Analysis, By End User
  - 8.8. Latin America Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 8.9. Latin America Anorexiants Market Attractiveness Analysis, By Country
    
    8.9.1. Brazil
    
    8.9.2. Mexico
    
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Anorexiants Market Analysis and Forecast, 2019-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  - 9.3. Middle East & Africa Anorexiants Market Attractiveness Analysis, By Drug Class
  - 9.4. Middle East & Africa Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  - 9.5. Middle East & Africa Anorexiants Market Attractiveness Analysis, By Route of Administration
  - 9.6. Middle East & Africa Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
  - 9.7. Middle East & Africa Anorexiants Market Attractiveness Analysis, By End User
  - 9.8. Middle East & Africa Anorexiants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 9.9. Middle East & Africa Anorexiants Market Attractiveness Analysis, By Country
    
    9.9.1. South Africa
    
    9.9.2. Saudi Arabia
    
    9.9.3. UAE
    
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
  - 10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Pfizer Inc.
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Johnson & Johnson
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. F. Hoffmann-La Roche Ltd.
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Teva Pharmaceuticals
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. Arena Pharmaceuticals GmbH
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Abbott
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Epic Pharma LLC.
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. Novo Nordisk A/S
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Novartis AG
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. Merck & Co., Inc.
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
    
    10.7.11. Catalent Pharma Solutions LLC
    
    10.7.11.1. Company Details
    
    10.7.11.2. Business Overview
    
    10.7.11.3. Product Portfolio
    
    10.7.11.4. Financial Insights
    
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.11.6. SWOT Analysis
    
    10.7.11.7. Geographic Footprint
    
    10.7.12. AstraZeneca
    
    10.7.12.1. Company Details
    
    10.7.12.2. Business Overview
    
    10.7.12.3. Product Portfolio
    
    10.7.12.4. Financial Insights
    
    10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.12.6. SWOT Analysis
    
    10.7.12.7. Geographic Footprint
    
    10.7.13. Takeda Pharmaceutical Company Limited
    
    10.7.13.1. Company Details
    
    10.7.13.2. Business Overview
    
    10.7.13.3. Product Portfolio
    
    10.7.13.4. Financial Insights
    
    10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.13.6. SWOT Analysis
    
    10.7.13.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 2. Global Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 3. Global Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 4. Global Anorexiants Market Value (US$ Mn), By Region, 2019-2033
- Table 5. North America Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 6. North America Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 7. North America Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 8. North America Anorexiants Market Value (US$ Mn), By Country, 2019-2033
- Table 9. The US Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 10. The US Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 11. The US Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 12. Canada Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 13. Canada Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 14. Canada Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 15. Europe Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 16. Europe Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 17. Europe Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 18. Europe Anorexiants Market Value (US$ Mn), By Country, 2019-2033
- Table 19. Germany Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 20. Germany Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 21. Germany Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 22. The UK Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 23. The UK Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 24. The UK Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 25. France Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 26. France Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 27. France Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 28. Spain Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 29. Spain Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 30. Spain Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 31. Italy Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 32. Italy Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 33. Italy Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 34. Russia Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 35. Russia Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 36. Russia Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 37. Netherland Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 38. Netherland Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 39. Netherland Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 40. Rest of Europe Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 41. Rest of Europe Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 42. Rest of Europe Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 43. Asia Pacific Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 44. Asia Pacific Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 45. Asia Pacific Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 46. Asia Pacific Anorexiants Market Value (US$ Mn), By Country, 2019-2033
- Table 47. China Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 48. China Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 49. China Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 50. India Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 51. India Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 52. India Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 53. Japan Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 54. Japan Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 55. Japan Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 56. South Korea Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 57. South Korea Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 58. South Korea Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 59. Australia Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 60. Australia Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 61. Australia Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 62. New Zealand Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 63. New Zealand Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 64. New Zealand Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 65. Singapore Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 66. Singapore Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 67. Singapore Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 68. Thailand Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 69. Thailand Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 70. Thailand Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 71. Vietnam Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 72. Vietnam Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 73. Vietnam Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 74. Rest of Asia Pacific Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 75. Rest of Asia Pacific Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 76. Rest of Asia Pacific Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 77. Latin America Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 78. Latin America Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 79. Latin America Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 80. Latin America Anorexiants Market Value (US$ Mn), By Country, 2019-2033
- Table 81. Brazil Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 82. Brazil Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 83. Brazil Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 84. Mexico Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 85. Mexico Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 86. Mexico Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 87. Rest of Latin America Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 88. Rest of Latin America Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 89. Rest of Latin America Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 90. Middle East & Africa Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 91. Middle East & Africa Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 92. Middle East & Africa Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 93. Middle East & Africa Anorexiants Market Value (US$ Mn), By Country, 2019-2033
- Table 94. South Africa Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 95. South Africa Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 96. South Africa Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 97. Saudi Arabia Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 98. Saudi Arabia Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 99. Saudi Arabia Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 100. UAE Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 101. UAE Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 102. UAE Anorexiants Market Value (US$ Mn), By End User, 2019-2033
- Table 103. Rest of Middle East & Africa Anorexiants Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 104. Rest of Middle East & Africa Anorexiants Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 105. Rest of Middle East & Africa Anorexiants Market Value (US$ Mn), By End User, 2019-2033
List of Figures
- Figure 1. Global Anorexiants Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Anorexiants Market
- Figure 5. Global Anorexiants Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 6. Global Anorexiants Market Attractiveness Analysis, By Drug Class
- Figure 7. Global Anorexiants Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 8. Global Anorexiants Market Attractiveness Analysis, By Route of Administration
- Figure 9. Global Anorexiants Market Analysis, By End User, 2019, 2023 and 2033
- Figure 10. Global Anorexiants Market Attractiveness Analysis, By End User
- Figure 11. Global Anorexiants Market Analysis, By Region, 2019, 2023 and 2033
- Figure 12. Global Anorexiants Market Attractiveness Analysis, By Region
- Figure 13. North America Anorexiants Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 14. North America Anorexiants Market Attractiveness Analysis, By Drug Class
- Figure 15. North America Anorexiants Market (US$ Mn), by Catecholamines, 2019-2033
- Figure 16. North America Anorexiants Market (US$ Mn), by Serotonin, 2019-2033
- Figure 17. North America Anorexiants Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 18. North America Anorexiants Market Attractiveness Analysis, By Route of Administration
- Figure 19. North America Anorexiants Market (US$ Mn), by Oral, 2019-2033
- Figure 20. North America Anorexiants Market (US$ Mn), by Subcutaneous, 2019-2033
- Figure 21. North America Anorexiants Market Analysis, By End User, 2019, 2023 and 2033
- Figure 22. North America Anorexiants Market Attractiveness Analysis, By End User
- Figure 23. North America Anorexiants Market (US$ Mn), by Institutional Sales, 2019-2033
- Figure 24. North America Anorexiants Market (US$ Mn), by Hospitals & Clinics, 2019-2033
- Figure 25. North America Anorexiants Market (US$ Mn), by Retail Sales, 2019-2033
- Figure 26. North America Anorexiants Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 27. North America Anorexiants Market (US$ Mn), by Others, 2019-2033
- Figure 28. North America Anorexiants Market Analysis, By Country, 2019, 2023 and 2033
- Figure 29. North America Anorexiants Market Attractiveness Analysis, By Country
- Figure 30. Europe Anorexiants Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 31. Europe Anorexiants Market Attractiveness Analysis, By Drug Class
- Figure 32. Europe Anorexiants Market (US$ Mn), by Catecholamines, 2019-2033
- Figure 33. Europe Anorexiants Market (US$ Mn), by Serotonin, 2019-2033
- Figure 34. Europe Anorexiants Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 35. Europe Anorexiants Market Attractiveness Analysis, By Route of Administration
- Figure 36. Europe Anorexiants Market (US$ Mn), by Oral, 2019-2033
- Figure 37. Europe Anorexiants Market (US$ Mn), by Subcutaneous, 2019-2033
- Figure 38. Europe Anorexiants Market Analysis, By End User, 2019, 2023 and 2033
- Figure 39. Europe Anorexiants Market Attractiveness Analysis, By End User
- Figure 40. Europe Anorexiants Market (US$ Mn), by Institutional Sales, 2019-2033
- Figure 41. Europe Anorexiants Market (US$ Mn), by Hospitals & Clinics, 2019-2033
- Figure 42. Europe Anorexiants Market (US$ Mn), by Retail Sales, 2019-2033
- Figure 43. Europe Anorexiants Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 44. Europe Anorexiants Market (US$ Mn), by Others, 2019-2033
- Figure 45. Europe Anorexiants Market Analysis, By Country, 2019, 2023 and 2033
- Figure 46. Europe Anorexiants Market Attractiveness Analysis, By Country
- Figure 47. Asia Pacific Anorexiants Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 48. Asia Pacific Anorexiants Market Attractiveness Analysis, By Drug Class
- Figure 49. Asia Pacific Anorexiants Market (US$ Mn), by Catecholamines, 2019-2033
- Figure 50. Asia Pacific Anorexiants Market (US$ Mn), by Serotonin, 2019-2033
- Figure 51. Asia Pacific Anorexiants Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 52. Asia Pacific Anorexiants Market Attractiveness Analysis, By Route of Administration
- Figure 53. Asia Pacific Anorexiants Market (US$ Mn), by Oral, 2019-2033
- Figure 54. Asia Pacific Anorexiants Market (US$ Mn), by Subcutaneous, 2019-2033
- Figure 55. Asia Pacific Anorexiants Market Analysis, By End User, 2019, 2023 and 2033
- Figure 56. Asia Pacific Anorexiants Market Attractiveness Analysis, By End User
- Figure 57. Asia Pacific Anorexiants Market (US$ Mn), by Institutional Sales, 2019-2033
- Figure 58. Asia Pacific Anorexiants Market (US$ Mn), by Hospitals & Clinics, 2019-2033
- Figure 59. Asia Pacific Anorexiants Market (US$ Mn), by Retail Sales, 2019-2033
- Figure 60. Asia Pacific Anorexiants Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 61. Asia Pacific Anorexiants Market (US$ Mn), by Others, 2019-2033
- Figure 62. Asia Pacific Anorexiants Market Analysis, By Country, 2019, 2023 and 2033
- Figure 63. Asia Pacific Anorexiants Market Attractiveness Analysis, By Country
- Figure 64. Latin America Anorexiants Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 65. Latin America Anorexiants Market Attractiveness Analysis, By Drug Class
- Figure 66. Latin America Anorexiants Market (US$ Mn), by Catecholamines, 2019-2033
- Figure 67. Latin America Anorexiants Market (US$ Mn), by Serotonin, 2019-2033
- Figure 68. Latin America Anorexiants Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 69. Latin America Anorexiants Market Attractiveness Analysis, By Route of Administration
- Figure 70. Latin America Anorexiants Market (US$ Mn), by Oral, 2019-2033
- Figure 71. Latin America Anorexiants Market (US$ Mn), by Subcutaneous, 2019-2033
- Figure 72. Latin America Anorexiants Market Analysis, By End User, 2019, 2023 and 2033
- Figure 73. Latin America Anorexiants Market Attractiveness Analysis, By End User
- Figure 74. Latin America Anorexiants Market (US$ Mn), by Institutional Sales, 2019-2033
- Figure 75. Latin America Anorexiants Market (US$ Mn), by Hospitals & Clinics, 2019-2033
- Figure 76. Latin America Anorexiants Market (US$ Mn), by Retail Sales, 2019-2033
- Figure 77. Latin America Anorexiants Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 78. Latin America Anorexiants Market (US$ Mn), by Others, 2019-2033
- Figure 79. Latin America Anorexiants Market Analysis, By Country, 2019, 2023 and 2033
- Figure 80. Latin America Anorexiants Market Attractiveness Analysis, By Country
- Figure 81. Middle East & Africa Anorexiants Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 82. Middle East & Africa Anorexiants Market Attractiveness Analysis, By Drug Class
- Figure 83. Middle East & Africa Anorexiants Market (US$ Mn), by Catecholamines, 2019-2033
- Figure 84. Middle East & Africa Anorexiants Market (US$ Mn), by Serotonin, 2019-2033
- Figure 85. Middle East & Africa Anorexiants Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 86. Middle East & Africa Anorexiants Market Attractiveness Analysis, By Route of Administration
- Figure 87. Middle East & Africa Anorexiants Market (US$ Mn), by Oral, 2019-2033
- Figure 88. Middle East & Africa Anorexiants Market (US$ Mn), by Subcutaneous, 2019-2033
- Figure 89. Middle East & Africa Anorexiants Market Analysis, By End User, 2019, 2023 and 2033
- Figure 90. Middle East & Africa Anorexiants Market Attractiveness Analysis, By End User
- Figure 91. Middle East & Africa Anorexiants Market (US$ Mn), by Institutional Sales, 2019-2033
- Figure 92. Middle East & Africa Anorexiants Market (US$ Mn), by Hospitals & Clinics, 2019-2033
- Figure 93. Middle East & Africa Anorexiants Market (US$ Mn), by Retail Sales, 2019-2033
- Figure 94. Middle East & Africa Anorexiants Market (US$ Mn), by Online Pharmacies, 2019-2033
- Figure 95. Middle East & Africa Anorexiants Market (US$ Mn), by Others, 2019-2033
- Figure 96. Middle East & Africa Anorexiants Market Analysis, By Country, 2019, 2023 and 2033
- Figure 97. Middle East & Africa Anorexiants Market Attractiveness Analysis, By Country
- Pfizer Inc Company Profile
- Johnson & Johnson
- F. Hoffmann-La Roche Ltd.
- Teva Pharmaceuticals
- Arena Pharmaceuticals GmbH
- Abbott Laboratories
- Epic Pharma LLC.
- Novo Nordisk A/S Company Profile
- Novartis AG Company Profile
- Merck & Co., Inc.
- Catalent Pharma Solutions LLC
- AstraZeneca Plc Company Profile
- Takeda Pharmaceutical Company Limited